Login
Request Demo

Is Real-world Data Latency Holding Back Your Co...

Japanese pharmaceutical leaders are moving beyond data latency concerns to focus on a more crucial question: How can patient data drive commercial success? The answer lies in understanding its strategic value.

Featured

Is Real-world Data Latency Holding Back Your Commercial S...

Japanese pharmaceutical leaders are moving beyond data latency concerns to focus on a more crucial question: How can patient data...

Understanding Regional Performance Variations in Japanese...

Unlock the complex drivers behind regional performance variations in Japan's pharmaceutical market through facility-level analysis that reveals actionable insights beyond...

First-Mover Advantage in Japan

In Japan's hospital-centric healthcare system, early adoption of facility-level intelligence creates lasting competitive advantages. Learn how sophisticated analytics drive better...

Cracking the Code of Multi-Indication Drugs

Multi-indication drugs open new possibilities for pharmaceutical marketing but also bring unique challenges. Approved for multiple conditions, these treatments require...

Search by

Case Studies

Published Research: Otsuka sheds light on Myelodysplasia Treatment in Australia with Patient-centric Intelligence

A recent study in eJHaem led by Anoop Enjeti, MD, PhD, in collaboration with Otsuka and Prospection, highlights the importance of treatment adherence and the need for more treatment options for Myelodysplastic Syndromes (MDS). It also showcases the critical role...

Published Research: How Johnson & Johnson Innovative Medicine Used Patient-centric Intelligence in Japan to Understand Care Advancements for Pulmonary Arterial Hypertension

A recent study by Johnson & Johnson Innovative Medicine Asia Pacific, in collaboration with Prospection, utilised patient-centric intelligence (PCI) in Japan to evaluate the persistence of endothelin receptor antagonists in pulmonary arterial hypertension (PAH) treatment.

Case Study: Treatment patterns in chronic lymphocytic leukaemia (CLL)

Learn how Prospection analysed real-world data and identified a shift towards newer novel agents for chronic lymphocytic leukemia (CLL) treatment, providing insights to support their client's launch planning, submission modelling and market preparations for their new treatment. Prospection analysed treatment...

Case Study: Treatment patterns in mantle cell lymphoma (MCL)

Learn how Prospection helped a pharma client understand the real-world utilization of medicines for mantle cell lymphoma (MCL). With depth of experience and analytics expertise, Prospection was able to identify patient treatment profiles using Australian Pharmaceutical Benefits Scheme (PBS) data....
View more

Podcasts & Webinars

Prospection CEO Daniel West on Patient-Centric Intelligence and Category Creation

Prospection's CEO Daniel West discusses the journey to build the future of patient-centric intelligence, unpacking the role that category design plays in defining business strategy and strengthening the company's goal to address care and share leaks in pharma. Listen to the po...
Read more

Navigating the Future — Pharma, Analytics Maturity and Shaping Healthcare’s Use of AI

Learn all about the roadmap to data maturity and AI adoption to get maximum value from your patient-centric intelligence.

  • 60 minutes

Patient-Centric Brand Growth with ChatGPT, Predictive AI and On-Demand Patient Journey

Explore the transformative power of AI, GPT and predictive analytics and how it can benefit patient-centric brand growth.

  • 60 minutes

A Healthy Dose of Data Science

Check out Tech Wire Asia podcast featuring Prospection's Co-CEO & Co-Founder, Eric Chung, as he discusses how Prospection is using...

  • 21:16 minutes

RWD providing answers to real world questions

Real world data provides patient and disease insights. Prospection Co-founders, Eric Chung, CEO and Dr Peter Cronin, Head of Data...

  • 26 minutes

Data to Real World Evidence

A Prospection Podcast with Dr Peter Cronin. What does it mean to be a trusted 3rd party provider? Prospection operates...

  • 8 minutes

Publications

Real-world study of the use of azacitidine in myelodysplasia in Australia

myelodysplasiaPCIreal world evidenceRWD
Read Publication

Real-World Study: Treatment Persistence in Pulmonary Arterial Hypertension Patients

comparative effectivenessERAshypertensionPAHreal world evidence
Read Publication

Persistence and adherence to second-generation antipsychotic long-acting injectable medications for schizophrenia

PCIreal world evidenceRWDschizophrenia
Read Publication

White Papers

No data was found